Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)
Public ClinicalTrials.gov record NCT03333057. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Randomized, Double-Masked, Saline-Controlled Study to Evaluate the Effect of Perfluorohexyloctane (NOV03) at Two Different Dosing Regimens on Signs and Symptoms of Dry Eye Disease (DED)
Study identification
- NCT ID
- NCT03333057
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novaliq GmbH
- Industry
- Enrollment
- 336 participants
Conditions and interventions
Conditions
Interventions
- NOV03 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2, 2018
- Primary completion
- May 17, 2018
- Completion
- Jul 26, 2018
- Last update posted
- Jan 3, 2022
2018
United States locations
- U.S. sites
- 11
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational site | Artesia | California | 90701 | — |
| Investigational Site | Newport Beach | California | 92660 | — |
| Investigational Site | Newport Beach | California | 92663 | — |
| Investigational Site | Santa Ana | California | 92705 | — |
| Investigational Site | Torrance | California | 90505 | — |
| Investigational site | Jacksonville | Florida | 32256 | — |
| Investigational Site | Lake Villa | Illinois | 60046 | — |
| Investigational Site | Kansas City | Missouri | 64111 | — |
| Investigational Site | Pennington | New Jersey | 08534 | — |
| Investigational Site | Nashville | Tennessee | 37205 | — |
| Investigational Site | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03333057, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2022 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03333057 live on ClinicalTrials.gov.